A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Celcuity Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 16,969 shares of CELC stock, worth $216,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,969
Previous 9,762 73.83%
Holding current value
$216,863
Previous $159,000 59.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$13.98 - $19.15 $100,753 - $138,014
7,207 Added 73.83%
16,969 $253,000
Q2 2024

Aug 14, 2024

BUY
$14.1 - $20.78 $137,644 - $202,854
9,762 New
9,762 $159,000

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $191M
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.